Safety of 24-Hour Infusion of ON 01910.Na in Patients With Advanced Cancer
Status:
Completed
Trial end date:
2011-11-01
Target enrollment:
Participant gender:
Summary
The primary purpose of this study is to determine the highest dose of ON 01910.Na that can be
safely given as an intravenous infusion over 24 hours once a week in a 3-week cycle to
patients with advanced solid tumors.